{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:35:30Z","timestamp":1793392530254,"version":"4.5.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH112420"],"award-info":[{"award-number":["R01MH112420"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["UL1GM118985"],"award-info":[{"award-number":["UL1GM118985"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Genentech Charitable Giving","award":["G-80078"],"award-info":[{"award-number":["G-80078"]}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2015211"],"award-info":[{"award-number":["2015211"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Weston Haven Foundation"},{"DOI":"10.13039\/100001018","name":"California Health Care Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Although people with schizophrenia are disproportionately affected by Hepatitis C virus (HCV) compared to the general population, HCV screening among US Medicaid recipients with schizophrenia has not been characterized. Following 1998 CDC recommendations for screening in high-risk populations, we estimated the proportion of Medicaid recipients with and without schizophrenia screened for HCV across states and over time. Examining patterns of screening will inform the current public health imperative to test all adults for HCV now that safer and more effective treatments are available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data are drawn from 1 353 424 Medicaid recipients aged 15\u201364 years with schizophrenia and frequency-matched controls from 2002 to 2012. Participants with known HCV infection one year prior and those dual-eligible for Medicare were excluded. Multivariable logistic regression estimated associations between predictor variables and HCV screening.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>HCV screening was low (&amp;lt;4%) but increased over time. Individuals with schizophrenia consistently showed higher screening compared to controls across years and states. Several demographic and clinical characteristics predicted higher screening, especially comorbid HIV (OR = 6.5; 95% CI = 6.0\u20137.0). Outpatient medical care utilization increased screening by nearly double in 2002 (OR = 1.8; CI = 1.7\u20131.9) and almost triple in 2012 (OR = 2.7; CI = 2.6\u20132.9).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Low screening was a missed opportunity to improve HCV prevention efforts and reduce liver-related mortality among people with schizophrenia. Greater COVID-19 disease severity in HCV patients and the availability of effective HCV treatments increase the urgency to improve HCV screening. Eliminating Medicaid restrictions and expanding statewide HIV policies to include HCV would have multiple public health benefits, particularly for people with schizophrenia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/schizbullopen\/sgab058","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T20:10:31Z","timestamp":1641499831000},"source":"Crossref","is-referenced-by-count":7,"title":["Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002\u20132012"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3245-6363","authenticated-orcid":false,"given":"Marilyn D","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, Weill Institute for Neurosciences, University of California San Francisco, CA, USA"},{"name":"Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8535-0920","authenticated-orcid":false,"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[{"name":"Rutgers University Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Walkup","sequence":"additional","affiliation":[{"name":"Rutgers University Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-9139","authenticated-orcid":false,"given":"Mandana","family":"Khalili","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, University of California San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Dahiya","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, Weill Institute for Neurosciences, University of California San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walker","family":"Keenan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Cournos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mangurian","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, Weill Institute for Neurosciences, University of California San Francisco, CA, USA"},{"name":"Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, CA, USA"},{"name":"Center for Vulnerable Populations at ZSFG, University of California San Francisco, CA, USA"},{"name":"Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"2022011801012106300_CIT0001","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2022011801012106300_CIT0002","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states","volume":"3","author":"Colton","year":"2006","journal-title":"Prev Chronic Dis."},{"key":"2022011801012106300_CIT0003","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"2022011801012106300_CIT0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2215-0366(15)00357-0","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis","volume":"3","author":"Hughes","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"2022011801012106300_CIT0005","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/01.aids.0000192067.94033.aa","article-title":"Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders","volume":"19","author":"Rosenberg","year":"2005","journal-title":"AIDS."},{"key":"2022011801012106300_CIT0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsat.2005.11.005","article-title":"Sexual risk behavior among persons dually diagnosed with severe mental illness and substance use disorder","volume":"30","author":"Meade","year":"2006","journal-title":"J Subst Abuse Treat."},{"key":"2022011801012106300_CIT0007","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/jama.289.18.2413","article-title":"Chronic hepatitis C virus infection","volume":"289","author":"Flamm","year":"2003","journal-title":"JAMA."},{"key":"2022011801012106300_CIT0008","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2215-0366(17)30253-5","article-title":"Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden","volume":"4","author":"Bauer-Staeb","year":"2017","journal-title":"Lancet Psychiatry."},{"key":"2022011801012106300_CIT0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.genhosppsych.2019.10.007","article-title":"Rates of hepatitis B and C in patients with schizophrenia: a meta-analysis","volume":"61","author":"Lluch","year":"2019","journal-title":"Gen Hosp Psychiatry."},{"key":"2022011801012106300_CIT0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with hepatitis C virus in the United States, 2003\u20132013","volume":"62","author":"Ly","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022011801012106300_CIT0011","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2022011801012106300_CIT0012","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1089\/aid.2013.0035","article-title":"Short communication: Interferon\/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV\/hepatitis C virus-coinfected patients","volume":"29","author":"Funk","year":"2013","journal-title":"AIDS Res Hum Retroviruses."},{"key":"2022011801012106300_CIT0013","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2012.02.012","article-title":"Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals","volume":"142","author":"Naggie","year":"2012","journal-title":"Gastroenterology."},{"key":"2022011801012106300_CIT0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/1756283X15587481","article-title":"The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment","volume":"8","author":"Lam","year":"2015","journal-title":"Therap Adv Gastroenterol."},{"key":"2022011801012106300_CIT0015","first-page":"117","volume-title":"Clin Liver Dis (Hoboken)","author":"IDSA-AASLD H","year":"2018"},{"key":"2022011801012106300_CIT0016","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","volume":"47","author":"Centers for Disease Control & Prevention","year":"1998","journal-title":"Morb Mortal Wkly Rep."},{"key":"2022011801012106300_CIT0017","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/313848","article-title":"1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"30","author":"USPHS\/IDSA Prevention of Opportunistic Infections Working Group","year":"2000","journal-title":"Clin Infect Dis."},{"key":"2022011801012106300_CIT0018","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep."},{"key":"2022011801012106300_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep."},{"key":"2022011801012106300_CIT0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1176\/ps.2008.59.8.917","article-title":"Medical services for clients in community mental health centers: results from a national survey","volume":"59","author":"Druss","year":"2008","journal-title":"Psychiatr Serv."},{"key":"2022011801012106300_CIT0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/01612840.2011.638415","article-title":"Exploring barriers to primary care for patients with severe mental illness: frontline patient and provider accounts","volume":"33","author":"Kaufman","year":"2012","journal-title":"Issues Ment Health Nurs."},{"key":"2022011801012106300_CIT0022","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1176\/appi.ps.54.8.1158","article-title":"Barriers to primary medical care among patients at a community mental health center","volume":"54","author":"Levinson Miller","year":"2003","journal-title":"Psychiatr Serv."},{"key":"2022011801012106300_CIT0023","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/cid\/cis616","article-title":"Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence","volume":"55","author":"Spradling","year":"2012","journal-title":"Clin Infect Dis."},{"key":"2022011801012106300_CIT0024","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2105\/AJPH.2016.303059","article-title":"Hepatitis C screening rate among underserved adults with serious mental illness receiving care in California Community Mental Health Centers","volume":"106","author":"Trager","year":"2016","journal-title":"Am J Public Health."},{"key":"2022011801012106300_CIT0025","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/liv.14804","article-title":"Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection","volume":"41","author":"Butt","year":"2021","journal-title":"Liver Int."},{"key":"2022011801012106300_CIT0026","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.12998\/wjcc.v9.i29.8749","article-title":"Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality","volume":"9","author":"Ronderos","year":"2021","journal-title":"World J Clin Cases."},{"key":"2022011801012106300_CIT0027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jcop.20422","article-title":"Screening for and prevalence of HIV and hepatitis C among an outpatient urban sample of people with serious mental illness and co-occurring substance abuse","volume":"39","author":"Himelhoch","year":"2011","journal-title":"J Community Psychol."},{"key":"2022011801012106300_CIT0028","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcma.2012.03.002","article-title":"Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions","volume":"75","author":"Hung","year":"2012","journal-title":"J Chin Med Assoc."},{"key":"2022011801012106300_CIT0029","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurpub\/cky142","article-title":"Hepatitis C prevalence and associated risk factors among individuals who are homeless and diagnosed with mental illness: at Home\/Chez Soi Study, Vancouver, BC","volume":"29","author":"Nikoo","year":"2019","journal-title":"Eur J Public Health."},{"key":"2022011801012106300_CIT0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ps.201600284","article-title":"Nonpsychiatric outpatient care for adults with serious mental illness in California: who is being left behind?","volume":"68","author":"Garcia","year":"2017","journal-title":"Psychiatr Serv."},{"key":"2022011801012106300_CIT0031","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1176\/ps.2008.59.8.847","article-title":"Access to medical care among persons with psychotic and major affective disorders","volume":"59","author":"Bradford","year":"2008","journal-title":"Psychiatr Serv."},{"key":"2022011801012106300_CIT0032","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0033-3182(97)71422-1","article-title":"Use of medical services by veterans with mental disorders","volume":"38","author":"Druss","year":"1997","journal-title":"Psychosomatics."},{"key":"2022011801012106300_CIT0033","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1176\/ajp.155.12.1775","article-title":"Mental disorders and access to medical care in the United States","volume":"155","author":"Druss","year":"1998","journal-title":"Am J Psychiatry."},{"key":"2022011801012106300_CIT0034"},{"key":"2022011801012106300_CIT0035","author":"Centers for Medicaid & Medicare Services","year":"1991-2014"},{"key":"2022011801012106300_CIT0036","volume-title":"Viral hepatitis strategic plan","author":"New York State Department of Health","year":"2004"},{"key":"2022011801012106300_CIT0037","year":"2013"},{"key":"2022011801012106300_CIT0038","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/003335490612100108","article-title":"Surveillance programs for chronic viral hepatitis in three health departments","volume":"121","author":"Fleming","year":"2006","journal-title":"Public Health Rep"},{"key":"2022011801012106300_CIT0039","author":"Centers for Medicare & Medicaid Services","year":"2006-2012"},{"key":"2022011801012106300_CIT0040","first-page":"408","article-title":"Prevalence of viremic hepatitis C virus infection by age, race\/ethnicity, and birthplace and disease awareness among viremic persons in the United States, 1999-2016","volume":"221","author":"Zou","year":"2020","journal-title":"J Infect Dis."},{"key":"2022011801012106300_CIT0041","doi-asserted-by":"crossref","first-page":"399","DOI":"10.15585\/mmwr.mm6914a2","article-title":"Vital signs: newly reported acute and chronic hepatitis C cases\u2015United States, 2009\u20132018","volume":"69","author":"Ryerson","year":"2020","journal-title":"Morb Mortal Wkly Rep."},{"key":"2022011801012106300_CIT0042","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1377\/hlthaff.2016.1044","article-title":"Data on race, ethnicity, and language largely incomplete for managed care plan members","volume":"36","author":"Ng","year":"2017","journal-title":"Health Aff (Millwood)."},{"key":"2022011801012106300_CIT0043","first-page":"1","volume-title":"CDC recommendations for hepatitis C screening among adults","author":"Schillie","year":"2020"},{"key":"2022011801012106300_CIT0044","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/medicina57060597","article-title":"Liver impairment and hematological changes in patients with chronic hepatitis C and COVID-19: a retrospective study after one year of pandemic","volume":"57","author":"Cerbu","year":"2021","journal-title":"Medicina"},{"key":"2022011801012106300_CIT0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J Hepatol."},{"key":"2022011801012106300_CIT0046","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2022011801012106300_CIT0047","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.30161","article-title":"Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology."},{"key":"2022011801012106300_CIT0048","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/liv.14135","article-title":"Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int."},{"key":"2022011801012106300_CIT0049","volume-title":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. No. WHO\/HIV\/2016.06","author":"World Health Organization","year":"2016"},{"issue":"1","key":"2022011801012106300_CIT0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12325-020-01535-3","article-title":"Estimating the year each state in the United States will achieve the World Health Organization\u2019s elimination targets for Hepatitis C","volume":"38","author":"Sulkowski","year":"2021","journal-title":"Adv Ther."},{"key":"2022011801012106300_CIT0051","author":"Center for Health Law and Policy Innovation: Harvard Law School"},{"key":"2022011801012106300_CIT0052","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1176\/ps.2010.61.8.830","article-title":"Health insurance coverage among persons with schizophrenia in the United States","volume":"61","author":"Khaykin","year":"2010","journal-title":"Psychiatr Serv."}],"container-title":["Schizophrenia Bulletin Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizbullopen\/advance-article-pdf\/doi\/10.1093\/schizbullopen\/sgab058\/42167114\/sgab058.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizbullopen\/article-pdf\/3\/1\/sgab058\/42225767\/sgab058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizbullopen\/article-pdf\/3\/1\/sgab058\/42225767\/sgab058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T01:02:01Z","timestamp":1642467721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizbullopen\/article\/doi\/10.1093\/schizbullopen\/sgab058\/6504977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/schizbullopen\/sgab058","relation":{},"ISSN":["2632-7899"],"issn-type":[{"value":"2632-7899","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]},"article-number":"sgab058"}}